Similar Articles |
|
The Motley Fool October 1, 2008 Shannon Zimmerman |
This Trend Is Just Beginning It's a great time to be an investor. No, really. |
The Motley Fool October 12, 2010 Selena Maranjian |
Don't Underestimate These Great Stocks Companies with rock-bottom P/Es could be true bargains. |
The Motley Fool December 21, 2006 Shannon Zimmerman |
The Worst Stock for 2007: Research In Motion Good companies don't always make good investments. But is RIM even a good company? Investors, take note. |
The Motley Fool November 20, 2009 Dan Caplinger |
7 Stocks That Give You Real Value Now that the rally has pushed share prices back up to somewhat pricier levels, you can't afford to get stuck with stocks that turn out to be value traps. Take a look at 7 real-value stocks. |
The Motley Fool December 13, 2011 |
A Brief History of Teva Pharmaceutical's Returns The good news is that, at 15 times earnings, Teva shares now look reasonably valued. |
The Motley Fool April 15, 2004 Salim Haji |
Deckers' Ugg-ly Valuation As shares of footwear firm Deckers Outdoor continue to soar, concerns about valuation and risk only increase. |
The Motley Fool September 8, 2004 Bill Mann |
The Self-Confidence of the Naive So many investors believe that they can generate above-average returns by concentrating on things that the market has already priced in. Better to look out longer term, where few others are. |
The Motley Fool January 15, 2009 Dan Caplinger |
Beware of "Bargain" Stocks Before you go picking cheap stocks willy-nilly, make sure you're not cutting corners on your research -- or you could get a nasty shock in the future. |
The Motley Fool August 16, 2010 Dan Caplinger |
Don't Ignore These Cheap Stocks Values abound. Don't miss the boat. |
The Motley Fool November 10, 2011 |
A Brief History of Capital One's Returns Capital One's price-to-book value has dropped off a cliff, falling by over 80% over the past 10 years. |
The Motley Fool November 17, 2011 |
A Brief History of Chevron's Returns The reason Chevron was such a boon to shareholders is explained here. |
The Motley Fool May 4, 2006 Stephen D. Simpson |
A More Realistic Bar for Barr Labs An unpleasant, but not altogether unexpected drop makes this generic drug company and better value for investors. |
The Motley Fool November 28, 2011 |
A Brief History of Amgen's Returns Amgen shares declined 17% over the past decade. What has happened? |
The Motley Fool December 12, 2006 Shannon Zimmerman |
Steal These Stocks! Despite what you may have heard, you can indeed beat the market while sleeping peacefully at night with world-class mutual funds. |
The Motley Fool August 11, 2005 Shannon Zimmerman |
The Pros and Cons of Energy Stocks Is now the time to buy or sell? Wise investors intent on tiptoeing through the oil patch may tap superior, long-term returns. |
The Motley Fool October 17, 2011 |
A Brief History of ExxonMobil's Returns How have ExxonMobil's dividends, growth, and valuation multiples each played a role over the past decade? |
The Motley Fool July 6, 2009 Dan Caplinger |
Are These Stocks Doomed to Drop? A number of stocks don't look anywhere near as cheap as they did a few months ago. Take a look at some examples: J.Crew... Massey Energy... Owens-Illinois... Temple-Inland... |
The Motley Fool August 24, 2010 David Meier |
Could Amgen Be a Multibagger? Strong returns on equity can generate powerful shareholder returns. |
The Motley Fool December 22, 2010 Stephen J. Marini |
Are These High-Yield Stocks Too Good to Be True? Look deep into the numbers on high yielders to avoid dividend traps. |
The Motley Fool October 22, 2010 Anand Chokkavelu |
7 Big Pharma Stocks Near 52-Week Lows Trolling the bottom for upside potential. |
The Motley Fool August 12, 2011 Matt Koppenheffer |
3 Stocks I Bought During the Panic With Mr. Market lowering prices on nearly everything, I did some shopping. |
The Motley Fool August 4, 2009 Matt Koppenheffer |
How Long Should You Ride This Rally? This rally in the market has been a great ride, but is it time to hop off? |
The Motley Fool November 30, 2011 |
A Brief History of Coach's Returns Coach shares returned a whopping 1,395% over the last decade. How'd they get there? |
The Motley Fool October 13, 2008 Dan Caplinger |
What Are Your Stocks Really Worth? Stop flying blind or your portfolio could end up on the side of a mountain. |
The Motley Fool October 5, 2011 Dan Caplinger |
Has Teva Pharmaceutical Become the Perfect Stock? Teva still looks poised to stay near perfection for the indefinite future. |
The Motley Fool April 24, 2009 Joe Magyer |
5 Value Traps to Avoid Right Now Don't get suckered into these cash sinkholes. |
The Motley Fool December 14, 2009 Rich Smith |
This Just In: Upgrades and Downgrades Piper Jaffray plays a wrong note on Teva. |
The Motley Fool March 30, 2006 Nathan Parmelee |
Time to Change My Tune on Apple? Apple's shares have fallen by 30%, but is that enough to make them an attractive value? |
The Motley Fool May 17, 2011 Andrew Tonner |
Does ConocoPhillips Deserve a Spot in Your Portfolio? A quick check of their numbers should help get us started. |
The Motley Fool June 2, 2005 Matt Thurmond |
Quality Systems or Not? Quality Systems' growth prospects were trading at a discount back in 2003. Those days are gone. But does that mean you shouldn't buy? |
The Motley Fool July 30, 2009 Selena Maranjian |
Making Money With Multiples These stats can help you compare companies to find great investments. |
The Motley Fool November 2, 2010 Jeremy Phillips |
Time to Sell Amgen? We're seeking danger signs among Fools' most beloved stocks. |
The Motley Fool August 1, 2005 Stephen D. Simpson |
Teva: Built to Last? Israeli generics giant Teva Pharmaceuticals is a high-quality company trading at a level that should still provide patient investors with solid long-term performance. |
The Motley Fool May 18, 2011 Jordan DiPietro |
Should You Buy and Hold Teva Pharmaceutical? The Israeli pharma firm passes all four of our retirement portfolio tests. |
The Motley Fool April 30, 2010 Dan Caplinger |
These Stocks Aren't Worth What You Think When you're trying to figure out what a company is worth, the stock price is the obvious first place to look. But if that's the only thing you look at, you're going to make some huge mistakes in your analysis -- and some investment decisions you'll later regret. |